The BreathID Hp collection system is intended for use to non-invasively measure changes in the 13CO2/12CO2 ratio of exhaled breath, which may be indicative of increased urease production associated with active Helicobacter pylori infection in the stomach.
For Office Collection, please contact Client Response at 260-266-1500 (Option 1) to request the BreathID Hp Collection Kit.
The BreathID Hp collection kit should not be used until four weeks or more after the end of treatment for the eradication of H. pylori as earlier post-treatment assessment may give false negative results.
The H. pylori stool antigen assay is FDA approved for use on specimens from pediatric patients. Safety and effectiveness has not been established in patients under the age of 3.
The patient should not have taken antimicrobials, proton pump inhibitors, or bismuth preparations within two weeks prior to administering the test. The patient should have fasted at least one hour before administering the solution. The Citrica Powder solution contains 84 mg of phenylalanine per packet. The test may not be suitable for patients with phenylketonuria whose dietary phenylalanine should be restricted.
Patients < 3 years of age
Use of a collection container other than the BreathID Hp Collection Bags
Protect from direct sunlight and sharp objects
Negative
Antimicrobials, proton pump inhibitors, and bismuth preparations are known to suppress H. pylori. Ingestion of these in the 2 weeks prior to H. pylori diagnostic testing may lead to false negative results. If clinically indicated, the test may be repeated on a new specimen obtained two weeks after discontinuing treatment. A positive result is still clinically valid.
The BreathID Hp collection system is intended for use to non-invasively measure changes in the 13CO2/12CO2 ratio of exhaled breath, which may be indicative of increased urease production associated with active Helicobacter pylori infection in the stomach.
3 to 5 days
01261020
83013